XML 55 R43.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders Equity (Details Narrative)
 1 Months Ended 9 Months Ended 12 Months Ended
Aug. 31, 2023
shares
Sep. 17, 2021
USD ($)
integer
$ / shares
shares
Aug. 31, 2022
shares
Sep. 30, 2025
USD ($)
$ / shares
shares
Sep. 30, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2024
$ / shares
May 07, 2024
USD ($)
$ / shares
Referral agreement term   5 years            
Common stock, par value | $ / shares       $ 0.001     $ 0.001  
Gross proceeds from sale       $ 1,149,288 $ 0      
Class of warrant or right, term   7 years            
Class of warrant or right, granted in period (in shares) | shares   30,000            
Exercise price of warrant (in usd per share) | $ / shares   $ 7.20            
Number of tranches | integer   2            
Warrants outstanding (in shares)   $ 149,551            
Warrants outstanding, term   7 years            
Shares vested (in shares) | shares 2,114   8,587 10,700        
Shares vested reversed due hange in the probability of performance criteria           $ 7,900    
Forfeited (in shares) | shares       19,300        
Measurement Input, Implied Volatility                
Warrants outstanding, measurement input   100.00%            
Measurement Input, Risk-free Yield                
Warrants outstanding, measurement input   1.17%            
Measurement Input, Share Price                
Warrants outstanding, stock price | $ / shares   $ 7.10            
ATM Agreement [Member]                
Common stock, par value | $ / shares               $ 0.001
Aggregate offering price               $ 15,000,000.0
Common stock, shares sold | shares       165,641        
Gross proceeds from sale       $ 1,184,740        
Net proceeds from sale       $ 1,149,288        
Top [Member]                
Referral agreement term   5 years